Artificial Intelligence In Oncology Drug Discovery Market

Global Artificial Intelligence In Oncology Drug Discovery Market Size, Trends & Analysis - Forecasts to 2028 By Application (Target Identification, Drug Design and Optimization, Biomarker Discovery, Others), By Component (Software & Services, Hardware), By End-user (Pharmaceutical & Biotechnology Companies, Research Institutions), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on May 8 2024 with the latest and most recent market numbers

Global Artificial Intelligence In Oncology Drug Discovery Market Size

The global artificial intelligence in oncology drug discovery market size is projected to grow at a CAGR value of 30.2% from 2023 to 2028. With the emergence of Artificial Intelligence (AI) technology, the field of oncology has witnessed tremendous achievements as it offers innovative solutions to expedite the drug discovery processes at a rapid pace. Furthermore, with the ever-growing volume of cancer-related data, including genomic and clinical trial data, AI-powered platforms and algorithms have proven instrumental in deciphering drug molecule intricacies, their complex patterns, and identifying potential drug targets more efficiently.

Over the past few years, Artificial Intelligence (AI) has received great attention in cancer care owing to its transformative potential in the field of oncology drug discovery. This is substantiated by the increasing number of strategic collaborations between pharmaceutical companies and AI technology companies for cancer drug discovery processes, resulting in the exponential revenue growth of the market.

Furthermore, the market is characterized by the growing adoption of AI technologies across the drug development pipeline, driven by the efficiency of AI solutions in revolutionizing various aspects of the drug discovery process. Moreover, the potential to advance the identification of promising drug targets, design more effective therapeutics, and identify patient-specific biomarkers has attracted significant investments from pharmaceutical companies and research institutions in AI technology solutions. On the other hand, AI technology providers continue to invest in R&D and technological innovation to maximize their profit margin in the market.

As AI applications within cancer care continue to proliferate and demonstrate their competence in improving the clinical trial outcome and efficiency of oncology drug discovery, it is expected to become one of the key elements in shaping the future of cancer treatment and patient care.

Global Artificial Intelligence In Oncology Drug Discovery Market: By Application

AI for target identification and drug design and optimization application in the cancer drug development market has dominated the 2022 market in terms of revenue share. This is because AI has proven its efficiency in analyzing vast datasets from proteomics, genomics, and molecular profiling for the identification of potential drug targets with higher precision and efficiency, accelerating the discovery of novel therapeutic avenues.

Similarly, AI-powered algorithms facilitate rapid designing and optimization of drug candidates, significantly reducing the time and cost involved in preclinical development, thereby driving revenue in the drug design and optimization market segment.

In addition, the expansion of AI usage in drug discovery has significantly impacted the biomarker discovery area, as it assists in sifting through complex biological data for the identification of biomarkers that can help in patient stratification and prediction of treatment response. This, in turn, improves personalized medicine approaches, accelerating the development of targeted therapies with greater efficacy.

Global Artificial Intelligence In Oncology Drug Discovery Market: By Component

The software & services segment captured the maximum revenue share in 2022 artificial intelligence in the oncology drug discovery market and is anticipated witness substantial growth during the forecast period.

The rising demand for AI-driven tools and platforms within the oncology pharmaceutical space to aid various applications such as predictive modeling, data analysis, and precision medicine is driving segment growth. Moreover, service providers that are engaged in delivering expertise in AI algorithm development, machine learning, and data curation among others are also gaining traction with the increasing deployment of AI tools, enabling pharmaceutical companies and research institutions to leverage cutting-edge AI technologies efficiently.

On the other hand, the hardware segment is expected to witness significant growth in the coming years owing to the notable technological advancements supported by the development of specialized hardware optimized for AI computations. Moreover, AI models, such as deep learning algorithms used in drug discovery, emphasize the need for massive computational power. This has resulted in enormous investment by companies in AI-specific hardware accelerators, such as application-specific integrated circuits (ASICs) and graphical processing units (GPUs).

Global Artificial Intelligence In Oncology Drug Discovery Market: By End-user

Pharmaceutical companies & biotechnology companies are estimated as the key revenue-generating end-users of the market in 2022. This is due to the well-established presence of the companies as well as their capability to invest heavily in advanced technologies such as machine learning and natural language processing among others.

For instance, in January 2023, BioNTech SE announced its agreement to acquire InstaDeep Ltd., an artificial intelligence and machine learning-based technology company. With this acquisition, BioNTech SE aimed to strengthen its presence in the arena of AI-powered drug discovery, design, and development.

On the other hand, research institutions are expected to grow significantly during the forecast period. By collaborating with pharmaceutical companies to accelerate AI research in drug development, research institutes are making significant contributions to the market.

Global Artificial Intelligence In Oncology Drug Discovery Market: By Region

North America (the United States, Canada, and Mexico) is estimated to account for the major revenue share of the market in the fiscal year 2022. Apart from the presence of a substantial number of software and technology suppliers in the U.S., another factor that has played a crucial role in the estimated revenue growth is the dominant position of the U.S. in AI-related research and development.

Moreover, the region is greatly benefited from a strong presence of drug-developing companies that are investing heavily in AI-driven solutions to accelerate their drug discovery processes. For instance, in October 2022, GSK plc, a global biopharma company, signed a three-year collaboration agreement with Tempus, a US-based precision medicine company. Under the collaboration terms, GSK can access Tempus’ AI-enabled platform to advance clinical trial design, speed up enrolment, and identify drug targets.

On the other hand, Asia-Pacific is anticipated to register the fastest growth during the forecast period, primarily due to the growing interest of pharmaceutical and biopharmaceutical companies in the AI-driven drug discovery process. Moreover, countries like China, Japan, and South Korea witnessed significant growth in investment flow in AI-based platforms and partnerships by market end-users. This increase in investment flow can be attributed to the rising concerns pertaining to healthcare service quality gaps between the patients and providers within cancer care.

Furthermore, the large and diverse patient pool in the region coupled with a continuously expanding biotechnology and pharmaceutical sector, is creating lucrative opportunities for market expansion in this region.

Global Artificial Intelligence In Oncology Drug Discovery Market Share and Competitor Analysis

IBM Watson, Benevolent AI, Atomwise, Exscientia, GNS Healthcare, Aria Pharmaceuticals, Euretos, Insitro, Cyclica, Insilico Medicine, and Iktos among others, are some key players operating in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

The market participants are continuously launching strategic collaborations to leverage AI in developing novel cancer treatments. For instance, in November 2022, the University of Texas MD Anderson Cancer Center and Exscientia plc today announced their strategic alliance to advance the development of novel small-molecule oncology therapies. As a result of this collaboration, Exscientia’s patient-centric artificial intelligence (AI) capabilities would be aligned with the drug discovery and development expertise of MD Anderson to drive the development of the next generation of oncology treatments. Such initiatives are anticipated to significantly propel market revenue in the coming years.

1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1 Strategic Opportunity & Attractiveness Analysis

1.1.1 Hot Revenue Pockets

1.1.2 Market Attractiveness Score

1.1.3 Revenue Impacting Opportunity

1.1.4 High-Growing Region/Country

1.1.5 Competitor Analysis

1.1.6 Consumer Analysis

1.2 Global Market Estimates' View

1.3 Strategic Insights Across Business Functions

1.3.1 For Chief Executive Officers

1.3.2 For Chief Marketing Officers

1.3.3 For Chief Strategy Officers

1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2 TECHNOLOGICAL TRENDS

2.1 Technological Adoption Rate

2.2 Current Trend Impact Analysis

2.3 Future Trend Impact Analysis

3 GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY DRUG DISCOVERY MARKET MARKET OUTLOOK

3.1 Market Pyramid Analysis

3.1.1 Introduction

3.1.2 Adjacent Market Opportunities

3.1.3 Ancillary Market Opportunities

3.2 Demand Side Analysis

3.2.1 Market Drivers: Impact Analysis

3.2.2 Market Restraints: Impact Analysis

3.2.3 Market Opportunities: Impact Analysis

3.2.4 Market Challenges: Impact Analysis

3.3 Supply Side Analysis

3.3.1 Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3 Value Chain Analysis

3.3.4 Trend Analysis

3.3.5 Gap Analysis

3.3.6 Cost Analysis

4 GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY DRUG DISCOVERY MARKET, BY APPLICATION

4.1 Introduction

4.2 Artificial Intelligence In Oncology Drug Discovery Market: Application Scope Key Takeaways

4.3 Revenue Growth Analysis, 2022 & 2028

4.4 Target Identification

4.4.1 Target Identification Market Estimates and Forecast, 2020-2028 (USD Million)

4.5 Drug Design and Optimization

4.5.1 Drug Design and Optimization Market Estimates and Forecast, 2020-2028 (USD Million)

4.6 Biomarker Discovery

4.6.1 Biomarker Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

4.7 Others

4.7.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)

5 GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY DRUG DISCOVERY MARKET, BY END USE

5.1 Introduction

5.2 Artificial Intelligence In Oncology Drug Discovery Market: End Use Scope Key Takeaways

5.3 Revenue Growth Analysis, 2022 & 2028

5.4 Pharmaceutical Companies & Biotechnology Companies

5.4.1 Pharmaceutical Companies & Biotechnology Companies Market Estimates and Forecast, 2020-2028 (USD Million)

5.5 Research Institutions

5.5.1 Research Institutions Market Estimates and Forecast, 2020-2028 (USD Million)

6 GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY DRUG DISCOVERY MARKET, BY COMPONENT

6.1 Introduction

6.2 Artificial Intelligence In Oncology Drug Discovery Market: Component Scope Key Takeaways

6.3 Revenue Growth Analysis, 2022 & 2028

6.4 Software & Services

6.4.1 Software & Services Market Estimates and Forecast, 2020-2028 (USD Million)

6.5 Hardware

6.5.1 Hardware Market Estimates and Forecast, 2020-2028 (USD Million)

7 GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY DRUG DISCOVERY MARKET, BY REGION

7.1 Introduction

7.2 North America Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.1 U.S. Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.1.1 By Application

7.2.4.1.2 By End Use

7.2.4.1.3 By Component

7.2.4.2 Canada Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.2.1 By Application

7.2.4.2.2 By End Use

7.2.4.2.3 By Component

7.2.4.3 Mexico Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.3.1 By Application

7.2.4.3.2 By End Use

7.2.4.3.3 By Component

7.3 Europe Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.1 Germany Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.1.1 By Application

7.3.4.1.2 By End Use

7.3.4.1.3 By Component

7.3.4.2 U.K. Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.2.1 By Application

7.3.4.2.2 By End Use

7.3.4.2.3 By Component

7.3.4.3 France Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.3.1 By Application

7.3.4.3.2 By End Use

7.3.4.3.3 By Component

7.3.4.4 Italy Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.4.1 By Application

7.3.4.4.2 By End Use

7.2.4.4.3 By Component

7.3.4.5 Spain Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.5.1 By Application

7.3.4.5.2 By End Use

7.2.4.5.3 By Component

7.3.4.6 Netherlands Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.6.1 By Application

7.3.4.6.2 By End Use

7.2.4.6.3 By Component

7.3.4.7 Rest of Europe Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.7.1 By Application

7.3.4.7.2 By End Use

7.2.4.7.3 By Component

7.4 Asia Pacific Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.1 China Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.1.1 By Application

7.4.4.1.2 By End Use

7.4.4.1.3 By Component

7.4.4.2 Japan Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.2.1 By Application

7.4.4.2.2 By End Use

7.4.4.2.3 By Component

7.4.4.3 India Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.3.1 By Application

7.4.4.3.2 By End Use

7.4.4.3.3 By Component

7.4.4.4 South Korea Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.4.1 By Application

7.4.4.4.2 By End Use

7.4.4.4.3 By Component

7.4.4.5 Singapore Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.5.1 By Application

7.4.4.5.2 By End Use

7.4.4.5.3 By Component

7.4.4.6 Malaysia Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.6.1 By Application

7.4.4.6.2 By End Use

7.4.4.6.3 By Component

7.4.4.7 Thailand Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1 By Application

7.4.4.7.2 By End Use

7.4.4.7.3 By Component

7.4.4.8 Indonesia Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.8.1 By Application

7.4.4.8.2 By End Use

7.4.4.8.3 By Component

7.4.4.9 Vietnam Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.9.1 By Application

7.4.4.9.2 By End Use

7.4.4.9.3 By Component

7.4.4.10 Taiwan Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.10.1 By Application

7.4.4.10.2 By End Use

7.4.4.10.3 By Component

7.4.4.11 Rest of Asia Pacific Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.11.1 By Application

7.4.4.11.2 By End Use

7.4.4.11.3 By Component

7.5 Middle East & Africa Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.1 Saudi Arabia Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.1.1 By Application

7.5.4.1.2 By End Use

7.5.4.1.3 By Component

7.5.4.2 U.A.E. Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.2.1 By Application

7.5.4.2.2 By End Use

7.5.4.2.3 By Component

7.5.4.3 Israel Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.3.1 By Application

7.5.4.3.2 By End Use

7.5.4.3.3 By Component

7.5.4.4 South Africa Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.4.1 By Application

7.5.4.4.2 By End Use

7.5.4.4.3 By Component

7.5.4.5 Rest of Middle East & Africa Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.5.1 By Application

7.5.4.5.2 By End Use

7.5.4.5.2 By Component

7.6 Central & South America Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.1 Brazil Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.1.1 By Application

7.6.4.1.2 By End Use

7.6.4.1.3 By Component

7.6.4.2 Argentina Eaporative Air Cooler Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.2.1 By Application

7.6.4.2.2 By End Use

7.6.4.2.3 By Component

7.6.4.3 Chile Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.3.1 By Application

7.6.4.3.2 By End Use

7.6.4.3.3 By Component

7.6.4.4 Rest of Central & South America Artificial Intelligence In Oncology Drug Discovery Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.4.1 By Application

7.6.4.4.2 By End Use

7.6.4.4.3 By Component

8 COMPETITIVE LANDCAPE

8.1 Company Market Share Analysis

8.2 Four Quadrant Positioning Matrix

8.2.1 Market Leaders

8.2.2 Market Visionaries

8.2.3 Market Challengers

8.2.4 Niche Market Players

8.3.4 Rest of the World

8.4 Company Profiles

8.4.1 IBM Watson

8.4.1.1 Business Description & Financial Analysis

8.4.1.2 SWOT Analysis

8.4.1.3 Products & Services Offered

8.4.1.4 Strategic Alliances between Business Partners

8.4.2 Benevolent AI

8.4.2.1 Business Description & Financial Analysis

8.4.2.2 SWOT Analysis

8.4.2.3 Products & Services Offered

8.4.2.4 Strategic Alliances between Business Partners

8.4.3 Atomwise

8.4.3.1 Business Description & Financial Analysis

8.4.3.2 SWOT Analysis

8.4.3.3 Products & Services Offered

8.4.3.4 Strategic Alliances between Business Partners

8.4.4 Exscientia

8.4.4.1 Business Description & Financial Analysis

8.4.4.2 SWOT Analysis

8.4.4.3 Products & Services Offered

8.4.4.4 Strategic Alliances between Business Partners

8.4.5 GNS Healthcare

8.4.5.1 Business Description & Financial Analysis

8.4.5.2 SWOT Analysis

8.4.5.3 Products & Services Offered

8.4.5.4 Strategic Alliances between Business Partners

8.4.6 Aria Pharmaceuticals

8.4.6.1 Business Description & Financial Analysis

8.4.6.2 SWOT Analysis

8.4.6.3 Products & Services Offered

8.4.6.4 Strategic Alliances between Business Partners

8.4.7 Euretos

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.8 Insitro

8.4.8.1 Business Description & Financial Analysis

8.4.8.2 SWOT Analysis

8.4.8.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.9 Cyclica

8.4.9.1 Business Description & Financial Analysis

8.4.9.2 SWOT Analysis

8.4.9.3 Products & Services Offered

8.4.9.4 Strategic Alliances between Business Partners

8.4.10 Insilico Medicine

8.4.10.1 Business Description & Financial Analysis

8.4.10.2 SWOT Analysis

8.4.10.3 Products & Services Offered

8.4.10.4 Strategic Alliances between Business Partners

8.4.11 Other Companies

8.4.11.1 Business Description & Financial Analysis

8.4.11.2 SWOT Analysis

8.4.11.3 Products & Services Offered

8.4.11.4 Strategic Alliances between Business Partners

9 RESEARCH METHODOLOGY

9.1 Market Introduction

9.1.1 Market Definition

9.1.2 Market Scope & Segmentation

9.2 Information Procurement

9.2.1 Secondary Research

9.2.1.1 Purchased Databases

9.2.1.2 GMEs Internal Data Repository

9.2.1.3 Secondary Resources & Third Party Perspectives

9.2.1.4 Company Information Sources

9.2.2 Primary Research

9.2.2.1 Various Type of Respondents for Primary Interviews

9.2.2.2 Number of Interviews Conducted throughout the Research Process

9.2.2.3 Primary Stakeholders

9.2.2.4 Discussion Guide for Primary Participants

9.2.3 Expert Panels

9.2.3.1 Expert Panels Across 30+ Industry

9.2.4 Paid Local Experts

9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

9.3 Market Estimation

9.3.1 Top-Down Approach

9.3.1.1 Macro-Economic Indicators Considered

9.3.1.2 Micro-Economic Indicators Considered

9.3.2 Bottom Up Approach

9.3.2.1 Company Share Analysis Approach

9.3.2.2 Estimation of Potential Product Sales

9.4 Data Triangulation

9.4.1 Data Collection

9.4.2 Time Series, Cross Sectional & Panel Data Analysis

9.4.3 Cluster Analysis

9.5 Analysis and Output

9.5.1 Inhouse AI Based Real Time Analytics Tool

9.5.2 Output From Desk & Primary Research

9.6 Research Assumptions & Limitations

9.7.1 Research Assumptions

9.7.2 Research Limitations

LIST OF TABLES

1 Global Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Mllion)

2 Target Identification Market, By Region, 2020-2028 (USD Mllion)

3 Drug Design and Optimization Market, By Region, 2020-2028 (USD Mllion)

4 Biomarker Discovery Market, By Region, 2020-2028 (USD Mllion)

5 Others Market, By Region, 2020-2028 (USD Mllion)

6 Global Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Mllion)

7 Pharmaceutical Companies & Biotechnology Companies Market, By Region, 2020-2028 (USD Mllion)

8 Research Institutions Market, By Region, 2020-2028 (USD Mllion)

9 Global Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Mllion)

10Software & Services Market, By Region, 2020-2028 (USD Mllion)

11Hardware Market, By Region, 2020-2028 (USD Mllion)

12Regional Analysis, 2020-2028 (USD Mllion)

13North America Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

14North America Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

15North America Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

16North America Artificial Intelligence In Oncology Drug Discovery Market, By Country, 2020-2028 (USD Million)

17U.S Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

18U.S Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

19U.S Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

20Canada Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

21Canada Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

22Canada Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

23Mexico Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

24Mexico Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

25Mexico Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

26Europe Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

27Europe Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

28Europe Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

29Germany Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

30Germany Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

31Germany Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

32UK Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

33UK Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

34UK Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

35France Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

36France Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

37France Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

38Italy Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

39Italy Artificial Intelligence In Oncology Drug Discovery Market, By T End Use Type, 2020-2028 (USD Million)

40Italy Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

41Spain Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

42Spain Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

43Spain Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

44Rest Of Europe Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

45Rest Of Europe Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

46Rest of Europe Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

47Asia Pacific Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

48Asia Pacific Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

49Asia Pacific Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

50Asia Pacific Artificial Intelligence In Oncology Drug Discovery Market, By Country, 2020-2028 (USD Million)

51China Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

52China Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

53China Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

54India Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

55India Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

56India Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

57Japan Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

58Japan Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

59Japan Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

60South Korea Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

61South Korea Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

62South Korea Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

63Middle East & Africa Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

64Middle East & Africa Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

65Middle East & Africa Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

66Middle East & Africa Artificial Intelligence In Oncology Drug Discovery Market, By Country, 2020-2028 (USD Million)

67Saudi Arabia Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

68Saudi Arabia Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

69Saudi Arabia Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

70UAE Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

71UAE Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

72UAE Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

73Central & South America Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

74Central & South America Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

75Central & South America Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

76Central & South America Artificial Intelligence In Oncology Drug Discovery Market, By Country, 2020-2028 (USD Million)

77Brazil Artificial Intelligence In Oncology Drug Discovery Market, By Application, 2020-2028 (USD Million)

78Brazil Artificial Intelligence In Oncology Drug Discovery Market, By End Use, 2020-2028 (USD Million)

79Brazil Artificial Intelligence In Oncology Drug Discovery Market, By Component, 2020-2028 (USD Million)

80IBM Watson: Products & Services Offering

81Benevolent AI: Products & Services Offering

82Atomwise: Products & Services Offering

83Exscientia: Products & Services Offering

84GNS Healthcare: Products & Services Offering

85Aria Pharmaceuticals: Products & Services Offering

86Euretos : Products & Services Offering

87Insitro: Products & Services Offering

88Cyclica, Inc: Products & Services Offering

89 Insilico Medicine: Products & Services Offering

90Other Companies: Products & Services Offering

LIST OF FIGURES

1 Global Artificial Intelligence In Oncology Drug Discovery Market Overview

2 Global Artificial Intelligence In Oncology Drug Discovery Market Value From 2020-2028 (USD Mllion)

3 Global Artificial Intelligence In Oncology Drug Discovery Market Share, By Application (2022)

4 Global Artificial Intelligence In Oncology Drug Discovery Market Share, By End Use (2022)

5 Global Artificial Intelligence In Oncology Drug Discovery Market Share, By Component (2022)

6 Global Artificial Intelligence In Oncology Drug Discovery Market, By Region (Asia Pacific Market)

7 Technological Trends In Global Artificial Intelligence In Oncology Drug Discovery Market

8 Four Quadrant Competitor Positioning Matrix

9 Impact Of Macro & Micro Indicators On The Market

10 Impact Of Key Drivers On The Global Artificial Intelligence In Oncology Drug Discovery Market

11 Impact Of Challenges On The Global Artificial Intelligence In Oncology Drug Discovery Market

12 Porter’s Five Forces Analysis

13 Global Artificial Intelligence In Oncology Drug Discovery Market: By Application Scope Key Takeaways

14 Global Artificial Intelligence In Oncology Drug Discovery Market, By Application Segment: Revenue Growth Analysis

15 Target Identification Market, By Region, 2020-2028 (USD Mllion)

16 Drug Design and Optimization Market, By Region, 2020-2028 (USD Mllion)

17 Biomarker Discovery Market, By Region, 2020-2028 (USD Mllion)

18 Others Market, By Region, 2020-2028 (USD Mllion)

19 Global Artificial Intelligence In Oncology Drug Discovery Market: By End Use Scope Key Takeaways

20 Global Artificial Intelligence In Oncology Drug Discovery Market, By End Use Segment: Revenue Growth Analysis

21 Pharmaceutical Companies & Biotechnology Companies Market, By Region, 2020-2028 (USD Mllion)

22 Research Institutions Market, By Region, 2020-2028 (USD Mllion)

23 Global Artificial Intelligence In Oncology Drug Discovery Market: By Component Scope Key Takeaways

24 Global Artificial Intelligence In Oncology Drug Discovery Market, By Component Segment: Revenue Growth Analysis

25 Software & Services Market, By Region, 2020-2028 (USD Mllion)

26 Hardware Market, By Region, 2020-2028 (USD Mllion)

27 Regional Segment: Revenue Growth Analysis

28 Global Artificial Intelligence In Oncology Drug Discovery Market: Regional Analysis

29 North America Artificial Intelligence In Oncology Drug Discovery Market Overview

30 North America Artificial Intelligence In Oncology Drug Discovery Market, By Application

31 North America Artificial Intelligence In Oncology Drug Discovery Market, By End Use

32 North America Artificial Intelligence In Oncology Drug Discovery Market, By Component

33 North America Artificial Intelligence In Oncology Drug Discovery Market, By Country

34 U.S. Artificial Intelligence In Oncology Drug Discovery Market, By Application

35 U.S. Artificial Intelligence In Oncology Drug Discovery Market, By End Use

36 U.S. Artificial Intelligence In Oncology Drug Discovery Market, By Component

37 Canada Artificial Intelligence In Oncology Drug Discovery Market, By Application

38 Canada Artificial Intelligence In Oncology Drug Discovery Market, By End Use

39 Canada Artificial Intelligence In Oncology Drug Discovery Market, By Component

40 Mexico Artificial Intelligence In Oncology Drug Discovery Market, By Application

41 Mexico Artificial Intelligence In Oncology Drug Discovery Market, By End Use

42 Mexico Artificial Intelligence In Oncology Drug Discovery Market, By Component

43 Four Quadrant Positioning Matrix

44 Company Market Share Analysis

45 IBM Watson: Company Snapshot

46 IBM Watson: SWOT Analysis

47 IBM Watson: Geographic Presence

48 Benevolent AI: Company Snapshot

49 Benevolent AI: SWOT Analysis

50 Benevolent AI: Geographic Presence

51 Atomwise: Company Snapshot

52 Atomwise: SWOT Analysis

53 Atomwise: Geographic Presence

54 Exscientia: Company Snapshot

55 Exscientia: Swot Analysis

56 Exscientia: Geographic Presence

57 GNS Healthcare: Company Snapshot

58 GNS Healthcare: SWOT Analysis

59 GNS Healthcare: Geographic Presence

60 Aria Pharmaceuticals: Company Snapshot

61 Aria Pharmaceuticals: SWOT Analysis

62 Aria Pharmaceuticals: Geographic Presence

63 Euretos : Company Snapshot

64 Euretos : SWOT Analysis

65 Euretos : Geographic Presence

66 Insitro: Company Snapshot

67 Insitro: SWOT Analysis

68 Insitro: Geographic Presence

69 Cyclica, Inc.: Company Snapshot

70 Cyclica, Inc.: SWOT Analysis

71 Cyclica, Inc.: Geographic Presence

72 Insilico Medicine: Company Snapshot

73 Insilico Medicine: SWOT Analysis

74 Insilico Medicine: Geographic Presence

75 Other Companies: Company Snapshot

76 Other Companies: SWOT Analysis

77 Other Companies: Geographic Presence

The Global Artificial Intelligence In Oncology Drug Discovery Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Artificial Intelligence In Oncology Drug Discovery Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market growth of global artificial intelligence in oncology drug discovery market?

The global artificial intelligence in oncology drug discovery market size is projected to grow at a CAGR value of 30.2% from 2023 to 2028.

Who are the major vendors in global artificial intelligence in oncology drug discovery market?

IBM Watson, Benevolent AI, Atomwise, Exscientia, GNS Healthcare, Aria Pharmaceuticals, Euretos, Insitro, Cyclica, Insilico Medicine, and Iktos among others, are some of the key players in the artificial intelligence in oncology drug discovery market.

What segment is dominating in global artificial intelligence in oncology drug discovery market?

What are the major drivers of global artificial intelligence in the oncology drug discovery market?

The ever-growing volume of cancer-related data, rising demand for AI-driven tools and platforms within the oncology pharmaceutical space, and enormous investment in advanced technologies such as machine learning and natural language processing are some key factors that are driving market revenue.